Treace Medical Concepts, Inc.
TMCI
$6.70
-$0.02-0.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.21% | -12.55% | -29.09% | -50.66% | -15.91% |
| Total Depreciation and Amortization | 36.56% | 52.91% | 65.58% | 102.00% | 114.36% |
| Total Amortization of Deferred Charges | 62.53% | 62.86% | 167.45% | 168.69% | 192.31% |
| Total Other Non-Cash Items | 55.74% | 85.30% | 87.51% | 108.26% | 41.14% |
| Change in Net Operating Assets | -5,457.93% | -161.04% | 29.13% | 77.17% | 97.41% |
| Cash from Operations | -4.94% | -7.50% | 19.86% | 21.69% | 39.66% |
| Capital Expenditure | 19.40% | -1.18% | 6.71% | 17.94% | 6.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.09% | 194.24% | 140.18% | 137.20% | 126.19% |
| Cash from Investing | 911.33% | 143.51% | 124.59% | 122.26% | 101.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.73% | -99.65% | -99.55% | -92.93% | -93.21% |
| Repurchase of Common Stock | 93.42% | 95.77% | 96.04% | 96.04% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | 100.00% |
| Cash from Financing | -95.22% | -99.85% | -99.73% | -99.59% | -98.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.91% | 74.86% | 105.95% | 106.87% | 70.55% |